Illustration of multiple orange alarm clocks floating against a blue background scattered at different angles as if suspende
Special Reports

The top 10 drugs losing US exclusivity in 2026

While megablockbusters naturally command significant attention, Fierce takes a chance each year to look at older medicines nearing their tumble over the patent cliff.
Fierce Madness Drug Name Tournament 2026 hero image

Fierce Madness Drug Name Tournament 2026: 1st round now open

Mar 17, 2026 6:00am
photo of a green light on a stoplight

FDA approves J&J, Protagonist's blockbuster-to-be psoriasis pill

Mar 18, 2026 11:33am
Bristol Myers Squibb Time Back SXSW panel

BMS brings Ashley Park aboard campaign honoring oncologists

Mar 18, 2026 11:25am
NuProbe

Sandoz expands biosimilar collaboration with Samsung Bioepis

Mar 18, 2026 11:05am
cancer target detection radiopharma radio

Gates-backed TerraPower sketches out $450M radioisotope facility

Mar 18, 2026 10:40am
More News

GSK used Flovent generic partner to 'game the system': senator

Mar 17, 2026 5:05pm

Indiana governor pledges $1B to life sciences, agroscience

Mar 17, 2026 4:45pm

Regulatory tracker: Sun wins 2nd approval for alopecia med

Mar 17, 2026 2:45pm

Hologic finds women’s health stagnating over 5 years of surveys

Mar 17, 2026 12:37pm